HCA CEO Hazen receives 54,934-share stock award
HCA Healthcare CEO Samuel N. Hazen reported equity transactions in company common stock.
Rhea-AI Filing Summary
HCA Healthcare CEO Samuel N. Hazen reported equity transactions in company common stock. On February 10, 2026, he acquired 54,934 shares at $0 per share as a grant tied to performance share units that fully vested at 200% of the original award.
On the same date, 21,323 shares were disposed of at $502.05 per share to satisfy tax withholding obligations, leaving 64,842 shares held directly. He also reports indirect ownership, including 200,000 shares held by a 2025 GRAT and 813,320 shares held by an LP.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
HAZEN SAMUEL N
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 54,934 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 21,323 | $502.05 | $10.71M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 64,842 shares (Direct);
Common Stock — 16,024 shares (Indirect, By HD Trust);
Common Stock — 16,731 shares (Indirect, By 2023 GST Trust);
Common Stock — 93,088 shares (Indirect, By 2023 Trust);
Common Stock — 178,289 shares (Indirect, By 2024 GRAT);
Common Stock — 200,000 shares (Indirect, By 2025 GRAT);
Common Stock — 813,320 shares (Indirect, By LP)
Footnotes (1)
- F1. On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HCA (HCA) CEO Samuel Hazen report?
HCA CEO Samuel Hazen reported a grant of 54,934 shares of common stock on February 10, 2026. The shares came from performance share units that vested based on 2023-2025 earnings per share performance, resulting in a 200% payout versus the original 27,467-unit grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
